Oxaliplatin has been used as the first choice for the adjuvant chemotherapy of colorectal cancer and it has significantly improved the outcomes in patients with colorectal cancer. However, hepatotoxicity is the potentially problematic adverse effect of oxaliplatin. The pathological evaluation of non-tumoral liver from patients with advanced colorectal cancer undergoing neoadjuvant oxaliplatin-based treatment has provided histological evidence of hepatic sinusoidal injury. Oxaliplatin-induced sinusoidal injury can persist for more than 1 year after the completion of chemotherapy, and the increase in splenic volume may be a predictor of irreversible sinusoidal damage. In this current study, the investigators aim to evaluate the values of potential biomarkers in diagnosing patients with oxaliplatin-induced gastroesophageal varices after colorectal cancer surgery.
Study Type
OBSERVATIONAL
Enrollment
370
the peripheral level of vWF
Department of Gastroenterology and Hepatology
Shanghai, Shanghai Municipality, China
the severity of portal hypertension
High portal pressure
Time frame: 1 day (the same time as diagnosis)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.